143 related articles for article (PubMed ID: 20852247)
1. Efficacy of a spot-on formulation of pyriprole on dogs infested with Sarcoptes scabiei.
Fourie JJ; Horak IG; de la Puente Redondo V
Vet Rec; 2010 Sep; 167(12):442-5. PubMed ID: 20852247
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of an imidacloprid/moxidectin combination against naturally acquired Sarcoptes scabiei infestations on dogs.
Fourie LJ; Heine J; Horak IG
Aust Vet J; 2006; 84(1-2):17-21. PubMed ID: 16498829
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the efficacy of an imidacloprid 10%/moxidectin 2.5% spot-on against Sarcoptes scabieivar canison dogs.
Fourie LJ; Du Rand C; Heine J
Parasitol Res; 2003 Jul; 90 Suppl 3():S135-6. PubMed ID: 12928880
[No Abstract] [Full Text] [Related]
4. Efficacy and safety of imidacloprid 10% plus moxidectin 2.5% spot-on in the treatment of sarcoptic mange and otoacariosis in dogs: results af a European field study.
Krieger K; Heine J; Dumont P; Hellmann K
Parasitol Res; 2005 Oct; 97 Suppl 1():S81-S88. PubMed ID: 16228280
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of fluralaner administered either orally or topically for the treatment of naturally acquired Sarcoptes scabiei var. canis infestation in dogs.
Taenzler J; Liebenberg J; Roepke RK; Frénais R; Heckeroth AR
Parasit Vectors; 2016 Jul; 9(1):392. PubMed ID: 27387742
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of a novel formulation of metaflumizone plus amitraz for the treatment of sarcoptic mange in dogs.
Fourie LJ; Kok DJ; du Plessis A; Rugg D
Vet Parasitol; 2007 Dec; 150(3):275-81. PubMed ID: 17931787
[TBL] [Abstract][Full Text] [Related]
7. Monthly application of 10 per cent moxidectin and 2.5 per cent imidacloprid spot-on to prevent relapses in generalised demodicosis: a pilot study.
Colombo S; Leone F; Vercelli A; Cornegliani L
Vet Rec; 2012 Sep; 171(11):272. PubMed ID: 22791522
[TBL] [Abstract][Full Text] [Related]
8. Clinical evaluation of the safety and efficacy of 10% imidacloprid + 2.5% moxidectin topical solution for the treatment of ear mite (Otodectes cynotis) infestations in dogs.
Arther RG; Davis WL; Jacobsen JA; Lewis VA; Settje TL
Vet Parasitol; 2015 May; 210(1-2):64-8. PubMed ID: 25801226
[TBL] [Abstract][Full Text] [Related]
9. Sarcoptes scabiei var. canis refractory to ivermectin treatment in two dogs.
Terada Y; Murayama N; Ikemura H; Morita T; Nagata M
Vet Dermatol; 2010 Dec; 21(6):608-12. PubMed ID: 20880016
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the activity of selamectin, imidacloprid and fipronil for the treatment of dogs infested experimentally with Ctenocephalides canis and Ctenocephalides felis felis.
Cadiergues MC; Caubet C; Franc M
Vet Rec; 2001 Dec; 149(23):704-6. PubMed ID: 11787782
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of a novel oral isoxazoline, sarolaner (Simparica™), for the treatment of sarcoptic mange in dogs.
Becskei C; De Bock F; Illambas J; Cherni JA; Fourie JJ; Lane M; Mahabir SP; Six RH
Vet Parasitol; 2016 May; 222():56-61. PubMed ID: 26928658
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of afoxolaner in a clinical field study in dogs naturally infested with Sarcoptes scabiei.
Beugnet F; de Vos C; Liebenberg J; Halos L; Larsen D; Fourie J
Parasite; 2016; 23():26. PubMed ID: 27317462
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of imidacloprid 10 per cent/moxidectin 2-5 per cent spot-on in the treatment of cheyletiellosis in dogs.
Loft KE; Willesen JL
Vet Rec; 2007 Apr; 160(15):528-9. PubMed ID: 17435103
[No Abstract] [Full Text] [Related]
14. Efficacy of orally administered fluralaner (Bravecto™) or topically applied imidacloprid/moxidectin (Advocate®) against generalized demodicosis in dogs.
Fourie JJ; Liebenberg JE; Horak IG; Taenzler J; Heckeroth AR; Frénais R
Parasit Vectors; 2015 Mar; 8():187. PubMed ID: 25881320
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of imidacloprid/moxidectin spot-on solution and fenbendazole in the treatment of dogs naturally infected with Angiostrongylus vasorum (Baillet, 1866).
Willesen JL; Kristensen AT; Jensen AL; Heine J; Koch J
Vet Parasitol; 2007 Jul; 147(3-4):258-64. PubMed ID: 17544583
[TBL] [Abstract][Full Text] [Related]
16. Treatment of canine generalized demodicosis with a 'spot-on' formulation containing 10% moxidectin and 2.5% imidacloprid (Advocate, Bayer Healthcare).
Mueller RS; Meyer D; Bensignor E; Sauter-Louis C
Vet Dermatol; 2009 Oct; 20(5-6):441-6. PubMed ID: 20178482
[TBL] [Abstract][Full Text] [Related]
17. A pilot trial evaluating the efficacy of a 10% imidacloprid/2.5% moxidectin spot-on formulation in the treatment of natural nasal capillariosis in dogs.
Veronesi F; Morganti G; Di Cesare A; Schaper R; Traversa D
Vet Parasitol; 2014 Feb; 200(1-2):133-8. PubMed ID: 24365240
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of a combination of imidacloprid 10%/permethrin 50% versus fipronil 10%/(S)-methoprene 12%, against ticks in naturally infected dogs.
Otranto D; Lia RP; Cantacessi C; Galli G; Paradies P; Mallia E; Capelli G
Vet Parasitol; 2005 Jun; 130(3-4):293-304. PubMed ID: 15893431
[TBL] [Abstract][Full Text] [Related]
19. Localised sarcoptic mange in dogs: a retrospective study of 10 cases.
Pin D; Bensignor E; Carlotti DN; Cadiergues MC
J Small Anim Pract; 2006 Oct; 47(10):611-4. PubMed ID: 17004955
[TBL] [Abstract][Full Text] [Related]
20. Treatment of canine-generalized demodicosis: a blind, randomized clinical trial comparing the efficacy of Advocate(Bayer Animal Health) with ivermectin.
Paterson TE; Halliwell RE; Fields PJ; Louw ML; Louw JP; Ball GS; Pinckney RD; McKibben JS
Vet Dermatol; 2009 Oct; 20(5-6):447-55. PubMed ID: 20178483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
